Plus Therapeutics (PSTV) Return on Assets (2011 - 2026)

Plus Therapeutics (PSTV) has 16 years of Return on Assets data on file, last reported at 0.01% in Q1 2026.

• Return on Assets for Q1 2026 came in at 0.01%, up 1.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.01% (up 1.0% YoY), and the FY2025 annual result was 0.01%, changed 0.0% from the prior year.
• Return on Assets declined to 0.01% in Q1 2026 per PSTV's latest filing, from 0.01% in the prior quarter.
• Over five years, Return on Assets peaked at 0.01% in Q1 2022 and troughed at 0.02% in Q4 2024.
• A 5-year average of 0.01% and a median of 0.01% in 2023 frame the typical range for Return on Assets.
• The sharpest annual moves came in 2024 and 2025: Return on Assets decreased 1 bps in 2024, then rose 1 bps in 2025.
• A 5-year view of Return on Assets shows it stood at 0.01% in 2022, then dropped by 25 bps to 0.01% in 2023, then slumped by 99 bps to 0.02% in 2024, then soared by 58 bps to 0.01% in 2025, then retreated by 14 bps to 0.01% in 2026.
• Business Quant data shows PSTV's Return on Assets at 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.01% in Q3 2025.